论文部分内容阅读
2型糖尿病为高发慢病之一,其并发症及死亡风险均高,并发急性冠状动脉综合征(ACS)也较为常见。而2型糖尿病伴新发ACS后与其继后心血管病(CV)死亡风险间关系罕有报道,现就此进行相关对照分析。受检对象为5 380例2型糖尿病患者,其中随机分为接受阿格列汀的治疗组2 701例,和接受安慰剂的对照组2 679例
Type 2 diabetes is one of the most common and chronic diseases with high complication and death risk. Complications of acute coronary syndrome (ACS) are also common. The relationship between type 2 diabetes with new-onset ACS and the risk of subsequent cardiovascular disease (CV) death is rarely reported and is now being analyzed in this context. Subjects were 5380 patients with type 2 diabetes mellitus who were randomized to 2 701 treatment-treated patients with alogliptin and 2679 patients treated with placebo